|
David Dingli, M.D., Ph.D.
![]() David Dingli, M.D., Ph.D.
Location:
Minnesota
SummaryThe purpose of my research is to develop and optimize the use of replicating viruses for cancer therapy. I am interested in understanding the dynamic interactions between tumors cells, therapeutic viruses and the immune system and how these interactions determine the outcome of therapy. Our approach enables us to develop novel viruses with altered dynamic properties that may lead to better tumor control. The laboratory lives at the interface between theory and experiment. We develop mathematical models to understand the outcomes of in vivo experiments and explore in silico therapeutic scenarios based on validated models. The models generate hypothesis that we utilize to design novel viruses that are then tested experimentally. We also study clonal evolution in hematopoiesis with special reference to hematopoietic neoplasms. Starting from normal hematopoiesis, we model tumor development and its response to therapy. In addition, we study the evolution of 'benign' clonal disorders such as paroxysmal nocturnal hemoglobinuria and non-malignant processes such as cyclic hematopoiesis and hematopoietic recovery after stem cell transplantation. Recent publicationsSee a listing of my publications Education
Fellowship
Ph.D.
–
Molecular Biology
Residency
Internship
M.D.
Visiting Scientist
–
Complexo Interdisciplinar, Department of Physics
Senior House Officer
Senior House Officer
Visiting Scientist
–
Program for Evolutionary Dynamics
Visiting Scientist
|
Legal restrictions and terms of use applicable to this site
Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.